Efficacy and safety of Ivarmacitinib in moderate-to-severe atopic dermatitis patients with or without previous systemic treatments: a post-hoc analysis of a phase III trial

Background Prior exposure to systemic treatments may affect treatment outcomes in moderate-to-severe atopic dermatitis (AD).Objective This study aimed to explore the efficacy and safety of Ivarmacitinib (SHR0302) in moderate-to-severe AD patients with or without previous systemic treatments.Methods...

Szczegółowa specyfikacja

Opis bibliograficzny

Główni autorzy:	Qingchun Diao, Ruiling Jia, Min Li, Peng Zhao, Fang Lu, Qin Zhang, Chunzhu Ning, Juan Long, Jiajia Li, Yan Huang, Yuyi Wang
Format:	Artigo
Język:	Inglês
Wydane:	Taylor & Francis Group 2025-12-01
Seria:	Journal of Dermatological Treatment
Hasła przedmiotowe:	Ivarmacitinib moderate-to-severe atopic dermatitis previous systemic treatments efficacy safety
Dostęp online:	https://www.tandfonline.com/doi/10.1080/09546634.2025.2591478
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!